Legislators
Bills
Statements
Lobbying
Travel
- Bills
- H.R.1352
H.R.1352: Increasing Access to Biosimilars Act of 2023
About This Bill
- Introduced March 3, 2023
- Latest Major Action Dec. 6, 2023
- See the two similar bills introduced in other congresses.
Bill Sponsor
Bill Version
- Introduced in House - March 3, 2023
What Lawmakers Are Saying About This Bill
Bill Actions
Date | Description |
---|---|
Dec. 6, 2023 |
Ordered to be Reported (Amended) by the Yeas and Nays: 44 - 0.
|
Dec. 6, 2023 |
Committee Consideration and Mark-up Session Held
|
Dec. 5, 2023 |
Committee Consideration and Mark-up Session Held
|
Nov. 15, 2023 |
Forwarded by Subcommittee to Full Committee by Voice Vote.
|
Nov. 15, 2023 |
Subcommittee Consideration and Mark-up Session Held
|
March 10, 2023 |
Referred to the Subcommittee on Health.
|
March 3, 2023 |
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
|
March 3, 2023 |
Introduced in the House by Richard Hudson (R-N.C.) |